- Jazz Pharmaceuticals plc stock price today and history
Jazz Pharmaceuticals plc (JAZZ) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Jazz Pharmaceuticals plc stock price
Jazz Pharmaceuticals plc latest news:
Former Celator Pharmaceuticals accountant, three others charged with insider trading
The Securities and Exchange Commission charged an accountant and three others with trading on confidential market-moving news about Celator Pharmaceuticals Inc., a New Jersey-based pharmaceutical company where Evan R. Kita, a CPA, formerly worked. The SEC alleges that Kita tipped two of his friends with confidential information about clinical trial results for Celator's cancer drug and its acquisition by Dublin-based Jazz Pharmaceuticals Plc almost three months later. Jazz Pharmaceuticals offered to pay a hefty premium in May 2016 to acquire Celator when its stock rose more than 400% in March 2016 after it announced positive results for its drug to treat leukemia. Daniel Perez and Richard Yu allegedly purchased Celator stock based on Kita's tips before the two announcements and agreed to share their trading profits with him, according to the SEC. Yu passed Kita's tips to his father, Chiang Yu, who also traded in advance of both announcements, the SEC says. The SEC's investigation is continuing. The Department of Justice also filed criminal charges on Wednesday against the four men.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Jazz Pharmac announces offering of $500 mln of exchangeable senior notes
Jazz Pharmaceuticals Plc(JAZZ). * Jazz Pharmaceuticals(JAZZ) announces offering of $500 million of exchangeable senior notes due 2024. * Jazz Pharmaceuticals (JAZZ) - to use net proceeds to repay all or substantial portion of $500 million of outstanding borrowings under revolving credit facility Source text for Eikon: Further company coverage:
Jazz Pharmaceuticals shares fall after results miss Street estimates
Jazz Pharmaceuticals PLC shares dropped in the extended session Tuesday after the biotech company fell short of Wall Street estimates for quarterly results and affirmed its outlook for the year. Jazz shares fell 7.9% to $140.30 after hours. The company reported second-quarter net income of $105.6 million, or $1.72 a share, compared to $114.5 million, or $1.85 a share, in the year-ago period. Adjusted earnings were $2.56 a share. Revenue rose to $394.4 million from $381.6 million in the year-ago period. Analysts surveyed by FactSet had estimated $2.75 a share on revenue of $410.9 million. For the year, Jazz estimates adjusted earnings of $10.70 to $11.30 a share on revenue of $1.63 billion to $1.7 billion. Analysts expect earnings of $11.02 a share on revenue of $1.66 billion.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Jazz Pharmaceuticals Q2 adjusted earnings per share $2.56
Jazz Pharmaceuticals Plc(JAZZ). * Jazz Pharmaceuticals(JAZZ) announces second quarter 2017 financial results. * Q2 adjusted earnings per share $2.56. * Q2 GAAP earnings per share $1.72. * Q2 earnings per share view $2.75 -- Thomson Reuters I/B/E/S. * Jazz Pharmaceuticals Plc (JAZZ) says affirming its full year 2017 financial guidance. * Qtrly total revenues $394.4 million, up 3 percent.
BRIEF-Jazz Pharmaceuticals and XL-protein GmbH enter into license agreement
Jazz Pharmaceuticals Plc(JAZZ). * Jazz Pharmaceuticals(JAZZ) and XL-protein GmbH enter into a license agreement on PASylation technology to develop long-acting asparaginase product candidates. * Jazz Pharmaceuticals (JAZZ) - agreement with XL-protein GmbH for rights to develop, manufacture and commercialize products using XLp's pasylation technology.
JetBlue Airways CorporationJBLU
Jewett-Cameron Trading CompanyJCTCF
Jiayuan.com International Ltd.DATE
Jinpan International LimitedJST
Jive Software, Inc.JIVE
JM Global Holding CompanyWYIG
JM Global Holding CompanyWYIGU
JM Global Holding CompanyWYIGW